German drugmaker Stada Arzneimittel's private-equity owners Bain Capital and Cinven are delaying a planned initial public offering of the company until September due to recent market uncertainties ...
German pharmaceuticals company Stada has postponed a planned initial public offering (IPO) in Frankfurt because of market volatility, two people familiar with the matter told Reuters on Tuesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback